Fedratinib Hydrochloride
Fedratinib Hydrochloride is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Inrebic. Available dosage form: capsule.
Drug Details
- Generic Name
- Fedratinib Hydrochloride
- Brand Names
- Inrebic
- Application Number
- NDA212327
- Sponsor
- Celgene Corporation
- NDC Codes
- 2
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- FEDRATINIB HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE INREBIC ® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF). INREBIC is a kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) ( 1 ).